96.00
price down icon0.37%   -0.36
after-market Dopo l'orario di chiusura: 96.00
loading
Precedente Chiudi:
$96.36
Aprire:
$96.435
Volume 24 ore:
794.09K
Relative Volume:
0.86
Capitalizzazione di mercato:
$5.49B
Reddito:
$360.35M
Utile/perdita netta:
$-149.57M
Rapporto P/E:
-32.43
EPS:
-2.96
Flusso di cassa netto:
$-81.27M
1 W Prestazione:
-2.54%
1M Prestazione:
-0.83%
6M Prestazione:
-40.45%
1 anno Prestazione:
-23.37%
Intervallo 1D:
Value
$95.93
$96.83
Intervallo di 1 settimana:
Value
$95.34
$100.33
Portata 52W:
Value
$77.10
$163.71

Glaukos Corporation Stock (GKOS) Company Profile

Name
Nome
Glaukos Corporation
Name
Telefono
949-367-9600
Name
Indirizzo
1 GLAUKOS WAY, ALISO VIEJO, CA
Name
Dipendente
995
Name
Cinguettio
@GlaukosCorp
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
GKOS's Discussions on Twitter

Confronta GKOS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
GKOS
Glaukos Corporation
96.00 5.51B 360.35M -149.57M -81.27M -2.96
Medical Devices icon
ABT
Abbott Laboratories
125.83 218.75B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
107.76 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
400.93 151.01B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.01 117.43B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.91 44.76B 5.54B 4.18B 623.10M 7.00

Glaukos Corporation Stock (GKOS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-01 Downgrade Wells Fargo Overweight → Equal Weight
2025-02-19 Aggiornamento Mizuho Neutral → Outperform
2024-12-11 Aggiornamento Citigroup Neutral → Buy
2024-12-06 Iniziato UBS Buy
2024-12-02 Downgrade Morgan Stanley Equal-Weight → Underweight
2024-07-10 Downgrade Citigroup Buy → Neutral
2024-05-06 Aggiornamento Jefferies Hold → Buy
2023-12-21 Aggiornamento JP Morgan Neutral → Overweight
2023-12-04 Iniziato Morgan Stanley Equal-Weight
2023-11-28 Iniziato Truist Buy
2023-11-08 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-06-07 Aggiornamento Piper Sandler Neutral → Overweight
2022-12-22 Iniziato Mizuho Neutral
2022-12-19 Aggiornamento JP Morgan Underweight → Neutral
2022-12-12 Aggiornamento Citigroup Neutral → Buy
2022-10-14 Ripresa Stephens Overweight
2022-10-04 Iniziato Needham Buy
2022-07-12 Aggiornamento Stifel Hold → Buy
2022-02-03 Aggiornamento William Blair Mkt Perform → Outperform
2022-01-19 Aggiornamento Wells Fargo Underweight → Equal Weight
2022-01-18 Aggiornamento BTIG Research Neutral → Buy
2021-11-03 Aggiornamento Stephens Equal-Weight → Overweight
2021-07-26 Downgrade Stephens Overweight → Equal-Weight
2021-07-20 Downgrade Wells Fargo Equal Weight → Underweight
2021-07-14 Downgrade Oppenheimer Outperform → Perform
2021-07-14 Downgrade William Blair Outperform → Mkt Perform
2021-04-08 Aggiornamento Oppenheimer Perform → Outperform
2021-01-29 Downgrade Piper Sandler Overweight → Neutral
2020-12-16 Aggiornamento Citigroup Sell → Neutral
2020-12-09 Iniziato Oppenheimer Perform
2020-11-17 Aggiornamento Wells Fargo Underweight → Equal Weight
2020-10-08 Downgrade JP Morgan Neutral → Underweight
2020-06-15 Iniziato Jefferies Hold
2020-03-05 Iniziato Citigroup Sell
2020-02-28 Downgrade JP Morgan Overweight → Neutral
2020-01-06 Aggiornamento Berenberg Hold → Buy
2019-12-12 Downgrade Wells Fargo Outperform → Underperform
2019-09-30 Downgrade BofA/Merrill Buy → Underperform
2019-03-08 Iniziato BTIG Research Neutral
2018-08-30 Iniziato Berenberg Hold
2018-08-29 Aggiornamento JP Morgan Neutral → Overweight
2018-08-03 Reiterato Stifel Hold
2018-06-21 Downgrade JP Morgan Overweight → Neutral
2018-04-13 Downgrade Stifel Buy → Hold
2018-03-01 Reiterato Cantor Fitzgerald Buy
2017-03-02 Reiterato Cantor Fitzgerald Overweight
2017-01-06 Aggiornamento Stifel Hold → Buy
2016-10-27 Iniziato Wells Fargo Outperform
Mostra tutto

Glaukos Corporation Borsa (GKOS) Ultime notizie

pulisher
12:53 PM

What analysts say about Glaukos Corporation stockPowerful market insights - Autocar Professional

12:53 PM
pulisher
04:30 AM

Is Glaukos Corporation a good long term investmentFree Consultation - Autocar Professional

04:30 AM
pulisher
Jul 22, 2025

Why We're Not Concerned About Glaukos Corporation's (NYSE:GKOS) Share Price - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

Glaukos Corporation Stock Analysis and ForecastExceptional market positioning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Glaukos Corporation stock priceFree Daily Trading Room Entry - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

What analysts say about Glaukos Corporation stock outlookFree Insider Trading Tips - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal

Jul 18, 2025
pulisher
Jul 17, 2025

September 19th Options Now Available For Glaukos (GKOS) - Nasdaq

Jul 17, 2025
pulisher
Jul 16, 2025

BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $117 - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

(GKOS) Investment Report - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 14, 2025

Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS) - simplywall.st

Jul 14, 2025
pulisher
Jul 14, 2025

BTIG Increases Glaukos (GKOS) Price Target Ahead of Q2 Results | - GuruFocus

Jul 14, 2025
pulisher
Jul 10, 2025

Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - BioSpace

Jul 10, 2025
pulisher
Jul 09, 2025

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks - Yahoo Finance

Jul 09, 2025
pulisher
Jul 09, 2025

Glaukos to Release Second Quarter 2025 Financial Results after M - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Press Release: Glaukos to Release Second Quarter 2025 Financial Results After Market Close on July 30 - 富途牛牛

Jul 09, 2025
pulisher
Jun 30, 2025

Glaukos Prepares for New Product Launches - Orange County Business Journal

Jun 30, 2025
pulisher
Jun 30, 2025

Glaukos Corporation(NYSE: GKOS) added to Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

Glaukos gains EU certification for iStent infinite and other MIGS devices - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - BioSpace

Jun 26, 2025
pulisher
Jun 25, 2025

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies | GKOS Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell | GKOS Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Trend Tracker for (GKOS) - news.stocktradersdaily.com

Jun 25, 2025
pulisher
Jun 25, 2025

Glaukos Receives EU Regulatory Certification for Devices and Technologies to Treat Glaucoma - 富途牛牛

Jun 25, 2025
pulisher
Jun 24, 2025

Glaukos Corporation: Delivering Consistent Growth (NYSE:GKOS) - Seeking Alpha

Jun 24, 2025
pulisher
Jun 16, 2025

Glaukos Trades Higher Than Medical Peers NYSE Composite - Kalkine Media

Jun 16, 2025
pulisher
Jun 16, 2025

What Makes Glaukos (GKOS) a New Buy Stock - Yahoo Finance

Jun 16, 2025
pulisher
Jun 14, 2025

Trading (GKOS) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Canada

Jun 13, 2025
pulisher
Jun 11, 2025

Glaukos Corp (GKOS) Shares Up 6.05% on Jun 11 - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect? - sharewise

Jun 11, 2025
pulisher
Jun 10, 2025

Here’s Why Glaukos (GKOS) Shares Traded Lower in Q1 - Insider Monkey

Jun 10, 2025
pulisher
Jun 04, 2025

Stifel maintains buy rating on Glaukos stock, $115 target unchanged By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

Glaukos at Jefferies Conference: Eyeing Interventional Success By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Glaukos at Jefferies Conference: Eyeing Interventional Success - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Stifel maintains buy rating on Glaukos stock, $115 target unchanged - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Glaukos at William Blair Conference: Eyeing Innovative Growth By Investing.com - Investing.com South Africa

Jun 04, 2025

Glaukos Corporation Azioni (GKOS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.67
price up icon 0.39%
medical_devices STE
$225.47
price up icon 0.80%
medical_devices PHG
$25.85
price up icon 3.32%
$86.43
price up icon 1.54%
$77.25
price up icon 0.99%
medical_devices EW
$76.91
price up icon 0.80%
Capitalizzazione:     |  Volume (24 ore):